A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest President Donald Trump has canceled the $35 insulin co-pay cap for certain Medicare programs.

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — posted to the Bluesky social media platform.

The final proposed model would have had Medicare pay less for drugs that receive accelerated approvals from the Food and Drug Administration (FDA ... such as the $35 per month cap on insulin costs, were not affected by Trump’s executive order.

This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes drugs, challenges facing the World Health Organization after funding cuts, lawsuits regarding insulin prices,

has announced that the US Food and Drug Administration (FDA) has cleared Tidepool Loop, an automated insulin dosing app intended for the management of type 1 diabetes (T1D) in those six years old ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions of its drug — Semglee cost $269 and a generic version cost $99 for the same amount,

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies show it lowers kidney-related complications by 24 per cent. This offers new hope for patients,

Like pretty much all fruits and vegetables, grapefruit can help improve your health in many ways. It’s packed with vitamins, minerals, antioxidants and other plant compounds that do a body good. Let’s dive in and learn what eating grapefruit every day does to your body.

Dubai: At Arab Health 2025 in Dubai, Emirates Health Services (EHS) is showcasing initiatives advancing heart and diabetes treatments. The first project is the Total Artificial Heart (TAH), developed in collaboration with the Texas Heart Institute.

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a process to differentiate immune-evading iPSCs,

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose levels in real-time in non-diabetics.

Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli Lilly, the manufacturer of Mounjaro, eating smaller, more frequent meals, avoiding fatty foods, and consuming bland foods, such as whole-wheat toast or brown rice, can help manage some of the drug's side effects.